牙齒再生市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、最終用戶、地區和競爭格局分類，2021-2031年

全球牙齒再生市場預計將從 2025 年的 58.3 億美元成長到 2031 年的 82.8 億美元，複合年成長率為 6.02%。

該市場涵蓋生物工程療法，例如幹細胞應用和生物活性支架，旨在再生受損牙齒組織並完全取代缺牙。推動市場成長的關鍵因素包括全球牙周病和牙齒脫落發病率的不斷上升，以及日益老化的人口尋求永久性生物修復方案以取代傳統植入。例如，為了說明這些疾病帶來的巨大經濟負擔，歐洲牙周病學會估計，到2024年，常見口腔疾病的直接治療費用將達到每年3,300億歐元，凸顯了開發耐用修復技術的必要性。

另一方面，阻礙市場擴張的一大挑戰是開發和商業化這些複雜生物治療方法的高成本。此外，嚴格的臨床核准監管要求會延緩產品上市，限制病患獲得治療的機會，從而阻礙這些先進再生醫學解決方案的快速普及。

市場促進因素

幹細胞療法和組織工程的進步正在從根本上重塑牙科市場，將牙科治療從人工替代轉向生物修復。研究人員擴大利用再生醫學，例如抗體藥物和幹細胞移植，來克服傳統植入在恢復牙齒全部活力方面的局限性，促進牙本質、牙髓和琺瑯質的自然再生。一項重大進展是，日本Start-UpsTregem BioPharma於2024年6月宣布，將於2024年9月啟動一種透過抑制USAG-1蛋白來再生牙齒的新藥的人體臨床試驗。此外，亞利桑那州口腔顎面外科醫師協會於2024年6月報告稱，一項基於幹細胞的牙髓再生臨床試驗取得了80%的成功率，標誌著該療法向商業化邁出了重要一步。

隨著全球口腔健康負擔日益加重，齲齒和牙周疾病的盛行率不斷上升，成為市場需求的主要促進因素。傳統的治療方法，例如根管治療和牙橋，無法解決生物組織的根本缺失問題，導致老齡化社會中無牙患者數量激增。這使得人們迫切需要再生醫學產品，這些產品不僅能夠修復損傷，還能逆轉損傷。 2024年11月的一篇《牙科新聞》報導凸顯了這一問題的嚴重性，該報道指出，世界衛生組織（WHO）目前估計，全球20歲以上人口中有7%的人完全喪失了牙齒，這強調了開發能夠從生物學根源上治療牙齒缺失的先進再生醫學干預措施的緊迫性。

市場挑戰

開發和商業化複雜生物治療方法的高成本是全球牙齒再生市場的主要障礙。這些涉及複雜幹細胞應用和生物活性支架的先進療法需要嚴格的監管流程和廣泛且昂貴的臨床試驗。因此，製造商被迫設定高價以收回投資，導致許多患者難以負擔治療費用，阻礙了市場滲透。

醫療費用支出本已十分龐大，這進一步加劇了經濟障礙。由於患者和保險公司在標準治療方面已經承擔了巨額費用，市場擴張舉步維艱，人們也不願承擔昂貴的生物工程替代療法的額外成本。美國牙醫協會 (ADA) 在 2024 年 12 月發布的報告凸顯了這種經濟壓力，報告顯示美國年度牙科支出已達 1,740 億美元。如此巨額的傳統治療方法支出表明，在預算緊張的環境下引入昂貴的新療法十分困難，這阻礙了再生醫學解決方案的廣泛商業化。

市場趨勢

基於胜肽的治療趨勢正引領牙科治療領域從機械修復轉向模擬天然琺瑯質形成的生物活性療法。這一趨勢包括使用自組裝胜肽，這些胜肽能夠滲透到早期齲損部位，並透過從唾液中吸收鈣和磷酸鹽，以非侵入性的方式再生牙齒結構。與僅修復受損區域的傳統填充物不同，這些仿生材料能夠與牙齒的生物基質融合，無需鑽牙即可恢復牙齒的完整性。這滿足了人們對預防性和微創治療的需求。該技術的商業性化發展令人矚目。根據《今日牙科》（Dentistry Today）2025年7月刊報道，自2024年1月以來，美國已有超過42萬名患者接受了基於胜肽的牙釉質修復技術治療，這表明再生醫學解決方案正在迅速被臨床應用。

同時，3D生物列印技術在客製化支架領域的應用，正透過建構患者特異性的可生物分解基質，革新齒槽骨再生方式。這些列印結構的設計旨在精準貼合患者的解剖缺損部位，提供暫時支撐，促進自然骨再生，最終被人體完全吸收。這避免了金屬網片植入後需要進行的二次取出手術。這種個人化方法能夠改善複雜重組病例的功能性結果，而傳統移植往往難以發揮作用。為了支持這項臨床進展，昆士蘭大學於2025年1月宣布，研究人員已成功將客製化的3D列印聚己內酯支架應用於另外9名患者的顎骨再生，顯示個人化結構再生技術正朝著廣泛應用的方向邁進。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球牙齒再生市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（硬組織、軟組織）
  • 依最終使用者（牙科診所、醫院等）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美牙齒再生市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲牙科再生市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區牙科再生市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲牙科再生市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲牙科再生市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球牙齒再生市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Institut Straumann AG
• Dentsply Sirona Inc
• 3M Company
• Integra LifeSciences Holdings Corporation
• ZimVie Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Tooth Regeneration Market is projected to expand from USD 5.83 Billion in 2025 to USD 8.28 Billion by 2031, registering a CAGR of 6.02%. This market encompasses bioengineered therapies, such as stem cell applications and bioactive scaffolds, designed to regrow damaged dental tissues or replace missing teeth entirely. Growth is primarily driven by the increasing global incidence of periodontal diseases and tooth loss, alongside an aging population seeking permanent biological alternatives to conventional implants. Highlighting the economic weight of these conditions, the European Federation of Periodontology estimated in 2024 that direct global treatment costs for common oral conditions amount to €330 billion annually, emphasizing the need for durable restorative innovations.

Conversely, a significant challenge hindering market expansion is the high cost associated with developing and commercializing these complex biological therapies. Furthermore, stringent regulatory requirements for clinical approval delay product launches, thereby restricting patient access and limiting the rapid adoption of these advanced regenerative solutions.

Market Driver

Advancements in Stem Cell Therapy and Tissue Engineering are fundamentally reshaping the market by transitioning dental care from synthetic replacements to biological restoration. Researchers are increasingly leveraging regenerative medicine, such as antibody-based drugs and stem cell reimplantation, to stimulate the natural regrowth of dentin, pulp, and enamel, addressing the limitations of traditional implants to restore full vitality. A pivotal development occurred when, according to Harvard Media, Japanese startup Toregem Biopharma announced in June 2024 that human clinical trials would commence in September 2024 for a novel drug designed to regenerate teeth by suppressing the USAG-1 protein. Additionally, Oral & Facial Surgeons of Arizona reported in June 2024 that recent clinical trials achieved an 80% success rate in regenerating dental pulp using stem cells, signaling a major leap toward commercial viability.

The Rising Prevalence of Dental Caries and Periodontal Diseases serves as the primary catalyst for market demand, as the global burden of oral health conditions intensifies. Conventional treatments like root canals and bridges often fail to address the underlying loss of biological tissue, leading to a surge in edentulism among aging populations and creating a critical need for regenerative products that reverse damage rather than merely patching it. Highlighting the severity of this issue, Dental News reported in November 2024 that the World Health Organization estimated 7% of individuals aged 20 and older worldwide now suffer from complete tooth loss, underscoring the urgent necessity for advanced regenerative interventions capable of treating tooth loss at its biological root.

Market Challenge

The high cost associated with developing and commercializing complex biological therapies acts as a primary obstruction to the Global Tooth Regeneration Market. These advanced treatments, which involve intricate stem cell applications and bioactive scaffolds, face stringent regulatory pathways that necessitate extensive and expensive clinical trials. Consequently, manufacturers are forced to set premium price points to recover their investments, thereby rendering these therapies financially out of reach for a significant portion of the patient population and preventing widespread market adoption.

This barrier of affordability is further exacerbated by the immense existing strain on oral healthcare expenditure. The market struggles to scale when patients and insurers are already contending with significant outlays for standard care, making them hesitant to absorb the additional costs of premium bioengineered alternatives. Highlighting this financial pressure, the American Dental Association reported in December 2024 that national dental expenditures in the United States reached $174 billion annually. This substantial spending on conventional treatments underscores the difficulty of introducing expensive new therapies into a budget-constrained environment, thereby stalling the broader commercialization of regenerative solutions.

Market Trends

The Focus on Peptide-Based Therapeutic Modalities is shifting the sector from mechanical repairs to bioactive treatments that mimic natural enamel formation. This trend involves the use of self-assembling peptides that infiltrate early-stage carious lesions, attracting calcium and phosphate from saliva to regenerate tooth structure non-invasively. Unlike traditional fillings which merely patch damage, these biomimetic agents integrate with the tooth's biological matrix to restore integrity without drilling, addressing the demand for preventative and minimally invasive care. Commercial scaling of this technology is evident; according to Dentistry Today in July 2025, more than 420,000 patients in the United States have been treated with peptide-based Curodont technology since January 2024, demonstrating the rapid clinical adoption of these regenerative solutions.

Simultaneously, the Integration of 3D Bioprinting for Custom Scaffolds is transforming alveolar bone regeneration by enabling the fabrication of patient-specific, biodegradable matrices. These printed structures are designed to match the precise anatomical defects of a patient, providing a temporary architecture that supports natural bone regrowth before fully resorbing, which eliminates the need for secondary removal surgeries associated with metallic meshes. This personalized approach enhances functional outcomes in complex reconstructive cases where standard grafts often fail. Validating this clinical progress, the University of Queensland announced in January 2025 that researchers successfully applied custom 3D-printed polycaprolactone scaffolds to regenerate jawbone in a further 9 patients, signaling a move towards widely available personalized structural regeneration.

Key Market Players

• Institut Straumann AG
• Dentsply Sirona Inc
• 3M Company
• Integra LifeSciences Holdings Corporation
• ZimVie Inc.

Report Scope

In this report, the Global Tooth Regeneration Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tooth Regeneration Market, By Type

• Hard Tissue
• Soft Tissue

Tooth Regeneration Market, By End User

• Dental Clinics
• Hospitals
• Others

Tooth Regeneration Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tooth Regeneration Market.

Available Customizations:

Global Tooth Regeneration Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tooth Regeneration Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Hard Tissue, Soft Tissue)
  • 5.2.2. By End User (Dental Clinics, Hospitals, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Tooth Regeneration Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tooth Regeneration Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Tooth Regeneration Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Tooth Regeneration Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Tooth Regeneration Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Tooth Regeneration Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. France Tooth Regeneration Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Tooth Regeneration Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Tooth Regeneration Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Tooth Regeneration Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia Pacific Tooth Regeneration Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Tooth Regeneration Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Tooth Regeneration Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Tooth Regeneration Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Tooth Regeneration Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Tooth Regeneration Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. Middle East & Africa Tooth Regeneration Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Tooth Regeneration Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Tooth Regeneration Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Tooth Regeneration Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. South America Tooth Regeneration Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Tooth Regeneration Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Tooth Regeneration Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Tooth Regeneration Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Tooth Regeneration Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Institut Straumann AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Dentsply Sirona Inc
• 15.3. 3M Company
• 15.4. Integra LifeSciences Holdings Corporation
• 15.5. ZimVie Inc.

16. Strategic Recommendations

17. About Us & Disclaimer